South Korea · Industrial & Consumer Products · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
5.78%
2025 (actual)
ROA
5.22%
2025 (actual)
Gross Margin
59.59%
2025 (actual)
Net Margin
16.63%
2025 (actual)
Total Assets
₩247,044.69M
2025 (actual)
Net Income
₩12,939.82M
2025 (actual)
Valuation
₩95,883.5M
2026 (forecast)
Stock Price
₩15,710
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-0.6 pt
Company
Sector average (own scale)
ROA
-1.4 pt
Company
Gross Margin
-3.6 pt
Company
Sector average
Net Margin
-5 pt
Company
Total Assets
+60.1%
Company
Sector average (own scale)
Net Income
+15.6%
Company
Sector average (own scale)
Valuation
+37.8%
Company
Sector average (own scale)
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Sam-A Pharm. Co., Ltd? It covers the balance sheet, income statement, cash flow and Equlion model projections.